Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/1999
09/16/1999CA2322728A1 31 human secreted proteins
09/16/1999CA2321677A1 Novel polypeptides and nucleic acids encoding the same which are useful for treating inner ear diseases
09/15/1999EP0941369A2 Dna for evaluating the progression potential of cervical lesions
09/15/1999EP0941368A2 Method for detection of metastatic prostate cancer
09/15/1999EP0941348A1 Enhanced transport with a plastid membrane transport protein
09/15/1999EP0941346A1 Secretory immunoglobulin a as a mucosal vaccine delivery system
09/15/1999EP0941345A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
09/15/1999EP0941344A1 HUMANIZED ANTI-CD11a ANTIBODIES
09/15/1999EP0941342A1 Human squalene epoxidase
09/15/1999EP0941341A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
09/15/1999EP0941337A1 Synthesis and purification of hepatitis c virus-like particles
09/15/1999EP0941336A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses
09/15/1999EP0941335A2 Streptococcus pneumoniae polynucleotides and sequences
09/15/1999EP0941334A2 Protease-activatable pseudomonas exotoxin a-like proproteins
09/15/1999EP0941332A2 Carrot antifreeze polypeptides
09/15/1999EP0941328A1 Human breast tumor-specific proteins
09/15/1999EP0941327A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor
09/15/1999EP0941326A1 Murine guanine nucleotide exchange factor (mngef) and human homologues thereof
09/15/1999EP0941323A1 Bone morphogenetic protein-16 (bmp-16) compositions
09/15/1999EP0941319A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences
09/15/1999EP0941316A1 Human p2x purinoreceptor
09/15/1999EP0941313A1 Prostate-specific kallikrein
09/15/1999EP0941252A1 Anti-p53 single-chain antibody fragments and their uses
09/15/1999EP0941251A1 Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same
09/15/1999EP0941249A1 Novel histamine h2 receptor
09/15/1999EP0941248A1 Platelet secretory transport protein
09/15/1999EP0941244A2 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a method of detecting auto-immune antibodies
09/15/1999EP0941240A1 New picornaviruses, vaccines and diagnostic kits
09/15/1999EP0941239A1 Vertebrate homologues of unc-53 protein of c. elegans
09/15/1999EP0941121A2 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies
09/15/1999EP0941118A2 Pharmaceutical antigen-antibody preparation
09/15/1999EP0941111A1 Hepatocyte growth factor antagonists
09/15/1999EP0567470B1 Pseudomonas peptide composition and method for producing the same
09/15/1999CN1228811A Modulators of BRCAI activity
09/14/1999US5952545 Nucleic acid molecules encoding cytochrome P450-type proteins involved in the brassinosteroid synthesis in plants
09/14/1999US5952483 Human IκB-β
09/14/1999US5952481 DNA encoding ubiquitin conjugating enzymes
09/14/1999US5952472 Anti-fibroblast growth factor-8 monoclonal antibody
09/14/1999US5952471 Antibody that binds to cluster w-4 polypeptide of human small cell lung carcinoma cells
09/14/1999US5952469 Murine UCP3 polypeptides
09/14/1999US5952462 Transition state analogs
09/14/1999US5952305 Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
09/14/1999US5952214 Human growth-related CDC10 homolog
09/14/1999US5952212 Anticarcinogenic agents and antidiabetic agents
09/14/1999US5952199 A protein that contains an immunoglobulin-like domain; antiproliferative/antitumor agents, treatment of rheumatoid arthritis, psoriasis, diabeties, glaucoma, muscular disorders and immune rejection of eye transplants
09/14/1999US5952187 Antiepileptic agent analog derivatized at the sulfamate moiety or the 9-carbon methyl group to add label for use in immunoassays or to add carrier for use as immunogen; for monitoring serum or plasma levels of drug
09/14/1999US5952181 Hybridizing polynucleotide sequence to complementary polynucleotide forming a complex, detecting complex formation; anticarcinogenic agent, treatment of psychological disorders, alzheimer's disease
09/14/1999US5952179 Screens for mutations in the anti-proliferation domain of human Bcl-2
09/14/1999US5952175 DNA encoding a human progesterone receptor complex p23-like protein
09/14/1999US5952169 Identification of DNA-damaging substances by means of cell lines capable of overexpressing poly (ADP-ribose)--polymerase
09/14/1999US5951986 Tandem synthetic HIV-1 peptides
09/14/1999US5951983 A light chain framework region derived from a human antibody, a heavy chain framework region derived from a human antibody and light chain cdrs of the non-human monoclonal antibody produced by the cell line deposited as atcc hb11423;
09/14/1999US5951982 Administering an antibody thaat binds an epitope of vcd44; antitumor,-metastasis and carciogenic agents
09/14/1999US5951973 Use of interleukin-4 (IL-4) to treat rheumatoid arthritis
09/14/1999CA1340747C Hiv-2 virus variants
09/14/1999CA1340741C Cloned genes encoding ig-cd4 fusion protiens and the use thereof
09/14/1999CA1340737C Process for the preparation of pasteurized immunoglobulin preparation
09/14/1999CA1340735C Htlv-iii envelope peptides
09/14/1999CA1340732C Sv40 expression vector containing hbxag as an expression marker
09/10/1999WO1999045393A1 Method of detecting axonal damage, associated disease states, and related monoclonal antibodies and protein controls therefor
09/10/1999WO1999045392A1 Diagnostic for metastatic prostate cancer
09/10/1999WO1999045135A1 Novel fdrg protein and nucleic acid molecules and uses therefor
09/10/1999WO1999045129A1 Method for the induction of pathogen resistance in plants
09/10/1999WO1999045116A2 Human homolog of a nuclear migration gene and its use
09/10/1999WO1999045115A1 Human synapse related glycoproteins (hsrp)
09/10/1999WO1999045114A2 Human semaphorin zsmf-7
09/10/1999WO1999045111A1 Lectomedin materials and methods
09/10/1999WO1999045110A1 V-like domain binding molecules
09/10/1999WO1999045108A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
09/10/1999WO1999045031A2 Cd147 binding molecules as therapeutics
09/10/1999WO1999045028A1 Monoclonal antibodies esm-1 protein specific, and use of said antibodies for detecting esm-1 protein
09/10/1999WO1999044645A1 Compositions and methods of treating tumors
09/10/1999WO1999035263A3 Il-17rh dna and polypeptides
09/10/1999WO1999033967A3 Novel nucleic acid and polypeptide with homology to the tnf-receptors
09/10/1999WO1999032644A3 Prostate cancer gene
09/10/1999WO1999032514A3 Sag: sensitive to apoptosis gene
09/10/1999WO1999031236A3 EXTENDED cDNAs FOR SECRETED PROTEINS
09/10/1999WO1999028489A9 Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer
09/10/1999WO1999028466A9 Compositions and methods of use of het
09/10/1999WO1999025817A9 Tc1-based transposon vectors
09/10/1999WO1999024472A8 Glycosylated antibodies and antibody fragments having reactive ketone groups
09/10/1999WO1999021992A3 Nucleic acid molecules encoding a glutamate receptor
09/10/1999WO1999020756A3 Human toll homologues
09/10/1999WO1999013907A9 Methods to improve immunogenicity of antigens and specificity of antibodies
09/10/1999WO1998005356A8 NOVEL FtsL
09/10/1999CA2322749A1 Cd147 binding molecules as therapeutics
09/10/1999CA2322731A1 Lectomedin materials and methods
09/10/1999CA2322621A1 V-like domain binding molecules
09/10/1999CA2322592A1 Use of a peptide or antibody in the manufacture of a medicament for treating an erbb protein medicated tumor in combination with irradiation
09/10/1999CA2322426A1 Diagnostic for metastatic prostate cancer
09/10/1999CA2322425A1 Novel fdrg protein and nucleic acid molecules and uses therefor
09/10/1999CA2322382A1 Method for the induction of pathogen resistance in plants
09/10/1999CA2322381A1 Human synapse related glycoproteins (hsrp)
09/10/1999CA2249661A1 Novel compounds
09/10/1999CA2249041A1 Novel compounds
09/08/1999EP0940468A1 Humanized antibody variable domain
09/08/1999EP0939835A1 Compositions and methods for treating viral infections
09/08/1999EP0939832A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus
09/08/1999EP0939824A1 Reagents and methods useful for detecting diseases of the breast
09/08/1999EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase